LTGO is Latigo Biotherapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $23.15. Market cap: $1.42B.
Stock snapshot
| Price | $23.15 |
| Market cap | $1.42B |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
About LTGO
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.
Related non-dividend companies
Other non-dividend stocks investors research alongside LTGO. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is LTGO's current stock price?
LTGO (Latigo Biotherapeutics, Inc.) is currently trading at $23.15.
Does LTGO pay a dividend?
LTGO (Latigo Biotherapeutics, Inc.) does not currently pay a regular dividend.
Track LTGO in DiviDrip
Add LTGO to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search LTGO and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.